Skip to Main Content

Paper Details

Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety.
Cancer Discov
72
2023
B7, B7-H3, B7-H3 CAR T cells, B7-H3-specific chimeric antigen receptor, CD14, CD163, CD276, CNS tumors, CSF, CSF-1, CXCL13, DIPG, Diffuse intrinsic pontine glioma, H3CAR, H3CARs, Patients, VCAM-, brainstem tumor, central nervous system (CNS) tumors, children, human, patient, patients, pontine glioma
Author NameAffiliation
Nicholas A VitanzaBen Towne Center for Childhood Cancer Research, Seattle Children's Research Institute
Nicholas A VitanzaSeattle Children's Hospital, University of Washington
Jeffrey G OjemannSeattle Children's Hospital and Department of Neurological Surgery, University of Washington
Michael E BerensThe Translational Genomics Research Institute (TGen)
Matthew D DunSchool of Biomedical Sciences and Pharmacy, College of Health
Matthew D DunHunter Medical Research Institute
Jessica B FosterChildren's Hospital of Philadelphia
Jessica B FosterUniversity of Pennsylvania Perelman School of Medicine
Sarah E S LearyBen Towne Center for Childhood Cancer Research, Seattle Children's Research Institute
Sarah E S LearySeattle Children's Hospital, University of Washington
Francisco A PerezSeattle Children's Hospital
Jeffrey R WhiteakerClinical Research Division, Fred Hutchinson Cancer Center
Lei ZhaoClinical Research Division, Fred Hutchinson Cancer Center
Amanda G PaulovichClinical Research Division, Fred Hutchinson Cancer Center
  • 1 - 14

Datasets

Release 1.2